Prodrugs: A Novel Approach of Drug Delivery

Author:

Gaur Rishabh1ORCID

Affiliation:

1. Department of Pharmacology, Roorkee College of Pharmacy, Roorkee, India

Abstract

In the last one-decade numbers of review and research, articles have been published on prodrugs. This shows the interest of researchers in prodrugs because of the advantages offered by them over other drug delivery systems. Prodrug design is a method to focus many of the issues that trouble drug discovery and development, such as solidity, virulence, solubility, permeability, and drug targeting. Prodrug design is an effective method for targeting medications by altering their physiochemical, pharmacological, or pharmacokinetic properties. Prodrugs account for about 10% to 14% of all drugs sanctioned worldwide. Prodrugs can be created for a variety of administration methods, including transdermal, oral, intravenous, and more. However, the oral route of administration is the most popular and preferable approach; hence, oral prodrugs are highlighted in this article. Our main objectives are to explain the fundamental ideas behind the prodrug strategy, give a rundown of successfully registered oral prodrugs, and evaluate the therapeutic gains made in contrast to the parent drug. In this review article, we have made an attempt to incorporate all the basic details of prodrugs like Introductions, classification, applications of prodrug design in diverse fields of drug development, and basic functional categories that are amenable to prodrug design are all covered in this article. Using electronic databases such Web of Science, Google Scholar, PubMed, Sci Finder, Reaxys, and Cochrane, a literature search was conducted to locate information.

Publisher

Science Publishing Group

Reference58 articles.

1. Sun, X.; Vilar, S.; Tatonetti, N. P. High-throughput methods for combinatorial drug discovery. Sci. Transl. Med., 2013, 5, 205-201.

2. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001, 46, 3–26.

3. Gupta, D.; Bhatia, D.; Dave, V.; Sutariya, V.; Varghese. Gupta. S. Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations., 2018, 23, 1719.

4. Knittel, J. J.; Zavod, R. M. Drug design and relationship of functional groups to pharmacologic activity. In: Lemke, T.; Williams, D. A.; Roche, V. F.; Zito, S. W. editors. Foye’s Principles of Medicinal Chemistry. 7th ed. Wolters Kluwer Lippincott Williams and Wilkins; London, UK: 2013. p. 51.

5. Beig, A.; Fine-Shamir, N.; Porat, D.; Lindley, D.; Miller, J. M.; Dahan, A. Concomitant solubility-permeability increase: Vitamin E TPGS vs. amorphous solid dispersion as oral delivery systems for etoposide. Eur. J. Pharm. Biopharm. Off. J. Arb. Fur. Pharm. Verfahr. EV., 2017, 121, 97–103.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3